Replies to post #41569 on NanoViricides Inc (NNVC)

[TheDane]

Maybe you're asking the wrong people? Why not call Dr. Seymour and see if he can answer these highly technical and somewhat irrelavent (to the normal investor) questions.

I think you'll find the technical answers are meaningless to 90% of the people following the board. I'm satisfied with this from the company ...

"This profound decrease in viral load is consistent with the observed substantial increase in length of survival upon nanoviricide treatment."

I trust these guys know what they are doing.

[BonelessCat]

1) You need to go look up the previous study reports and then get back to us.
2) You also need to go read up on the effects of H1N1 on lung and other respiratory tissue. There is a reason for lethality that goes beyond simply overwhelming the immune system.

[incubus-now]

very possible that those responding to you have already discussed these issues dozens of times and already know the answers through their own dd - company releases.

why be invested in something where one doesn't know how it works and what existing results have already been reported?

it always seems difficult to sift through their prs as scientists write them, not public relations firms. no fluff, just the facts. minimal recalling of previous info as these releases are an expense. the company is extremely efficient controlling costs which is something we should all celebrate. the only downside is, we, as investors, must do more of our own reading to come to our own conclusions.